Socio-economic burden of disease: Survivorship costs for bladder cancer

This publication has 37 references indexed in Scilit:

• Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
  New England Journal of Medicine, 2013
• Recurrence at Three Months and High-grade Recurrence as Prognostic Factor of Progression in Multivariate Analysis of T1G2 Bladder Tumors
  Urology, 2009
• The present and future burden of urinary bladder cancer in the world
  World Journal of Urology, 2009
• Economic Impact of Tumor Markers in Bladder Cancer Surveillance
  Urology, 2008
• Muscle-Invasive Urothelial Carcinoma of the Bladder
  Urology, 2007
• Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
  European Urology, 2006
• Follow-up Cost of Breast Cancer Patients with Localized Disease After Primary Treatment: a Randomized Trial
  Breast Cancer Research and Treatment, 2005
• A SURVEILLANCE SCHEDULE FOR G1Ta BLADDER CANCER ALLOWING EFFICIENT USE OF CHECK CYSTOSCOPY AND SAFE DISCHARGE AT 5 YEARS BASED ON A 25-YEAR PROSPECTIVE DATABASE
  Journal of Urology, 2005
• THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCER
  Journal of Urology, 2000
• Cost of patient follow-up after potentially curative lung cancer treatment
  The Journal of Thoracic and Cardiovascular Surgery, 1996